NM
Newtyn Management Portfolio holdings
AUM
$660M
This Quarter Return
-4.94%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$632M
AUM Growth
+$632M
(+10%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
16.06%
Top 10 Holdings %
Top 10 Hldgs %
71.75%
Holding
36
New
3
Increased
8
Reduced
7
Closed
5
Top Buys
| 1 |
MRP
Millrose Properties, Inc.
MRP
|
$53M |
| 2 |
Cannae Holdings
CNNE
|
$49.7M |
| 3 |
DoubleVerify
DV
|
$12M |
| 4 |
AIV
Aimco
AIV
|
$10.8M |
| 5 |
MAGN
Magnera Corporation
MAGN
|
$7.26M |
Top Sells
| 1 |
Solventum
SOLV
|
$10.9M |
| 2 |
Bristow Group
VTOL
|
$9.65M |
| 3 |
Hawaiian Electric Industries
HE
|
$6.81M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$5.5M |
| 5 |
GRAL
GRAIL, Inc. Common Stock
GRAL
|
$4.28M |
Sector Composition
| 1 | Healthcare | 26.13% |
| 2 | Real Estate | 20.6% |
| 3 | Communication Services | 15.45% |
| 4 | Consumer Discretionary | 13.34% |
| 5 | Technology | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Abeona Therapeutics
ABEO
$350M
| $2.28M | 0.36% | 480,000 +100,000 | +26% | +$476K |
|
|
THRD
27
DELISTED
Third Harmonic Bio
THRD
| $2.2M | 0.35% | +635,150 | New | +$2.2M |
|
28
Atea Pharmaceuticals
AVIR
$267M
| $1.73M | 0.27% | 580,000 | – | – |
|
29
89bio
ETNB
$1.34B
| $1.45M | 0.23% | 200,000 -40,000 | -17% | -$291K |
|
30
Mural Oncology
MURA
$35.7M
| $718K | 0.11% | 570,000 | – | – |
|
|
31
Bristow Group
VTOL
$1.11B
| $571K | 0.09% | 18,080 -305,634 | -94% | -$9.65M |
|
|
32
Hawaiian Electric Industries
HE
$2.24B
| – | – | -700,000 | Closed | -$6.81M |
|
33
Olema Pharmaceuticals
OLMA
$375M
| – | – | -140,000 | Closed | -$816K |
|
|
34
Solventum
SOLV
$12.7B
| – | – | -164,529 | Closed | -$10.9M |
|
|
RVNC
35
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – | -1,810,000 | Closed | -$5.5M |
|
|
LFLYW
36
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
| – | – | -634,640 | Closed | -$10.2K |
|